Wildcat Capital Management, LLC
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Jul 22, 2026. SEC CIK 1582384.
- Reported value$228.5m
- Positions3
Holdings: 3 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Frontier Group Holdings IncULCC | COM | 35909R108 | 222 | 97.1% | 28,061,351 | Unchanged | |
| Allogene Therapeutics IncALLO | COM | 019770106 | 6.1 | 2.7% | 2,920,787 | Unchanged | |
| Chime Finl IncCHYM | COM SHS CL A | 16935C109 | 0.5 | 0.2% | 23,874 | New+23,874 |
Source: SEC EDGAR, Form 13F-HR, accession 0001999371-26-015582 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.